References
1. Holsten T, Bens S, Oyen F, et al. Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis. Eur J Hum Genet.2018;26(8):1083-1093.
2. Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature.2018;555(7697):469-474.
3. Kehrer-Sawatzki H, Kordes U, Seiffert S, et al. Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1. Mol Genet Genomic Med. 2018.
4. Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet.2009;46(1):68-72.
5. Ibrahim GM, Huang A, Halliday W, et al. Cribriform neuroepithelial tumour: novel clinicopathological, ultrastructural and cytogenetic findings. Acta Neuropathol. 2011;122(4):511-514.
6. Maitre E, Bertrand P, Maingonnat C, et al. New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.Oncotarget. 2018;9(48):28866-28876.
7. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood. 2016;127(20):2375-2390.